DOCN vs PATH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 05, 2026

DOCN

42.7
AI Score
VS
DOCN Wins

PATH

40.2
AI Score

Investment Advisor Scores

DOCN

43score
Recommendation
HOLD

PATH

40score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DOCN PATH Winner
Forward P/E 46.9484 14.5773 PATH
PEG Ratio 1.5379 0.4165 PATH
Revenue Growth 28.6% 13.4% DOCN
Earnings Growth -24.5% 2280.8% PATH
Tradestie Score 42.7/100 40.2/100 DOCN
Profit Margin 23.3% 21.0% DOCN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

DOCN 1M: -39.5% · 3M: -40.4% PATH 1M: -3.7% · 3M: -15.9%

Current Technical Phase

DOCN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.9%), weak momentum, RSI 35

RSI (14): 34.5 · Price: $79.52

PATH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.0%), weak momentum, RSI 41

RSI (14): 40.9 · Price: $12.83

Fundamentals Snapshot

Metric DOCN PATH
Market Cap — —
Forward P/E 40.4 16.8
Trailing P/E 270.0 19.4
Revenue (TTM) — —
Revenue Growth 0.4% 0.1%
Gross Margin 0.5% 0.8%
Operating Margin 0.1% 0.1%
EPS 0.29 0.67
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, DOCN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.